ATE315082T1 - Myeloider koloniestimulierungsfaktor und verwendungen davon - Google Patents
Myeloider koloniestimulierungsfaktor und verwendungen davonInfo
- Publication number
- ATE315082T1 ATE315082T1 AT01905087T AT01905087T ATE315082T1 AT E315082 T1 ATE315082 T1 AT E315082T1 AT 01905087 T AT01905087 T AT 01905087T AT 01905087 T AT01905087 T AT 01905087T AT E315082 T1 ATE315082 T1 AT E315082T1
- Authority
- AT
- Austria
- Prior art keywords
- stimulating factor
- colony stimulating
- myeloid colony
- csf5
- hyaluronidase
- Prior art date
Links
- 102000007644 Colony-Stimulating Factors Human genes 0.000 title abstract 3
- 108010071942 Colony-Stimulating Factors Proteins 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 206010065553 Bone marrow failure Diseases 0.000 abstract 1
- 101000962530 Homo sapiens Hyaluronidase-1 Proteins 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 229960002773 hyaluronidase Drugs 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000008629 immune suppression Effects 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17791300P | 2000-01-25 | 2000-01-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE315082T1 true ATE315082T1 (de) | 2006-02-15 |
Family
ID=22650424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01905087T ATE315082T1 (de) | 2000-01-25 | 2001-01-25 | Myeloider koloniestimulierungsfaktor und verwendungen davon |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1250422B1 (de) |
| JP (1) | JP2004500079A (de) |
| AT (1) | ATE315082T1 (de) |
| AU (1) | AU784155B2 (de) |
| CA (1) | CA2398539C (de) |
| DE (1) | DE60116466T2 (de) |
| DK (1) | DK1250422T3 (de) |
| ES (1) | ES2259024T3 (de) |
| WO (1) | WO2001055357A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2330213A1 (de) | 2003-03-05 | 2011-06-08 | Halozyme, Inc. | Lösliches Hyaluronidaseglykoprotein (sHASEGP), Verfahren zu dessen Herstellung, Verwendungen und pharmazeutische Zusammensetzunge, die dieses umfassen |
| KR101454646B1 (ko) * | 2012-11-05 | 2014-10-27 | (주)한국비엠아이 | 히알루로니다아제의 안정화 제제 및 이를 포함하는 액상제제 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6123938A (en) * | 1996-10-17 | 2000-09-26 | The Regents Of The University Of California | Human urinary hyaluronidase |
-
2001
- 2001-01-25 EP EP01905087A patent/EP1250422B1/de not_active Expired - Lifetime
- 2001-01-25 DE DE60116466T patent/DE60116466T2/de not_active Expired - Lifetime
- 2001-01-25 ES ES01905087T patent/ES2259024T3/es not_active Expired - Lifetime
- 2001-01-25 WO PCT/US2001/002575 patent/WO2001055357A2/en not_active Ceased
- 2001-01-25 JP JP2001554388A patent/JP2004500079A/ja active Pending
- 2001-01-25 AT AT01905087T patent/ATE315082T1/de not_active IP Right Cessation
- 2001-01-25 DK DK01905087T patent/DK1250422T3/da active
- 2001-01-25 AU AU33004/01A patent/AU784155B2/en not_active Ceased
- 2001-01-25 CA CA2398539A patent/CA2398539C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU3300401A (en) | 2001-08-07 |
| AU784155B2 (en) | 2006-02-09 |
| DK1250422T3 (da) | 2006-05-29 |
| CA2398539A1 (en) | 2001-08-02 |
| DE60116466T2 (de) | 2006-09-28 |
| EP1250422A2 (de) | 2002-10-23 |
| JP2004500079A (ja) | 2004-01-08 |
| CA2398539C (en) | 2011-05-31 |
| WO2001055357A3 (en) | 2002-03-28 |
| WO2001055357A2 (en) | 2001-08-02 |
| DE60116466D1 (de) | 2006-03-30 |
| EP1250422B1 (de) | 2006-01-04 |
| ES2259024T3 (es) | 2006-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60140794D1 (de) | Von casein abgeleitete peptide und deren anwendung für die therapie | |
| EA200601575A1 (ru) | Казеиновые пептиды и их терапевтическое применение | |
| MXPA05000880A (es) | Probioticos para funciones neuromusculares del intestino. | |
| DK0753053T3 (da) | Alfavirus-cDNA-vektorer | |
| EP1385466A4 (de) | Onkolytische virustherapie | |
| MX9603925A (es) | Combinaciones de anticoagulantes y proteinas activas tromboliticamente, y usos de las mismas. | |
| DE69942176D1 (de) | Choline-bindende proteine derivate aus pneumokoken als impfstoff | |
| WO1996040940A3 (en) | A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases | |
| IL166166A0 (en) | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders | |
| IL165858A (en) | Pharmaceutical preparation for treating human malignancies with arginine deprivation and uses thereof | |
| DE69833876D1 (de) | Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren | |
| KR20040078639A (ko) | 카세인 유도 펩타이드 및 이들의 치료 용도 | |
| BR0109928A (pt) | Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal | |
| DE60116466D1 (de) | Myeloider koloniestimulierungsfaktor und verwendungen davon | |
| MD990258A (en) | Method of treatment of the acute viral hepatitis B | |
| DE60130775D1 (de) | Stimulierung der neutrophilfunktion zur behandlung von entzündlichen darmerkrankungen | |
| ATE458495T1 (de) | Therapeutische zubereitung für autoimmune erkrankungen | |
| DE60223564D1 (de) | Therapeutische impfzusammensetzung zur verhütung und behandlung von erkrankungen bei säugetieren | |
| AU2003253894A1 (en) | Combination therapies with ftc for the treatment of hepatitis b virus infection | |
| WO2024040030A3 (en) | Treating protein misfolding disorders | |
| ATE386542T1 (de) | Mittel zur stimulation des immunsystems | |
| GR950100316A (el) | Φαρμακευτικο παρασκευασμα βασιζομενο σε αιωρημα εμβρυικων κυτταρων με δραση ανοσοποιητικης υποκαταστασης και μεθοδος θεραπειας του συνδρομου της επικτητης μολυνσης ανοσοποιητικης ανεπαρκειας (hiv) με τη χρηση αυτου του παρασκευασματος. | |
| UA42977A (uk) | Спосіб визначення антагоністичної активності біфіформу |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1250422 Country of ref document: EP |
|
| EEIH | Change in the person of patent owner | ||
| REN | Ceased due to non-payment of the annual fee |